ライフサイエンスコーパス: oxidized low-density lipoprotein

1 c cholesterol efflux and decreased uptake of oxidized low density lipoprotein.

2 esions, in apoptotic cells, and circulate in oxidized low density lipoprotein.

3 ent for neointima formation by components of oxidized low density lipoprotein.

4 es for the SR-A-mediated cell association of oxidized low density lipoprotein.

5 nhibited mesangial cell apoptosis induced by oxidized low density lipoprotein.

6 osition or in the serum antibody response to oxidized low-density lipoprotein.

7 T cells and an IgG1 isotype response toward oxidized low-density lipoprotein.

8 n of p38 mitogen-activated protein kinase by oxidized low-density lipoprotein.

9 nds that influence oxidative stress, such as oxidized low-density lipoprotein.

10 idation and measurement of autoantibodies to oxidized low-density lipoprotein.

11 e and specific assays to measure circulating oxidized low-density lipoprotein.

12 scavenger receptor ligands, acetylated, and oxidized low-density lipoprotein.

13 ta3 receptor ligation restores the uptake of oxidized low-density lipoprotein.

14 es most significantly with markers of plasma-oxidized low-density lipoprotein.

15 rombospondin-1, collagen types I and IV, and oxidized low-density lipoprotein.

16 result of inhibition of atherogenic forms of oxidized low-density lipoprotein.

17 associated with blood glucose, but not with oxidized low-density lipoprotein.

18 ion complexity and colocalized with C5aR and oxidized low-density lipoprotein.

19 We found 328 SNPs associated with oxidized low-density lipoprotein.

20 against bacterial phosphorylcholine but not oxidized low-density lipoprotein.

21 therosclerotic lesions, apoptotic cells, and oxidized low density lipoproteins.

22 Exposure of monocytes to oxidized low-density lipoprotein, 7-ketocholesterol, pho

23 c CD4(+) T cells and had IgG2a antibodies to oxidized low-density lipoprotein (a disease-related anti

24 B scavenger receptor, binds and internalizes oxidized low density lipoprotein, a key event in the dev

25 ions arise from lipid oxidation and generate oxidized low-density lipoprotein, a powerful inflammator

26 Oxidized low-density lipoprotein accumulates in atherosc

27 nt of plasma triglyceride-rich lipoproteins, oxidized low-density lipoproteins, adipokines, and cytok

28 so inhibited CD36 mRNA expression induced by oxidized low density lipoprotein and 15-deoxyDelta(12,14

29 ges, CXCL16 promoted internalization of both oxidized low density lipoprotein and high density lipopr

30 rotein has a wide range of ligands including oxidized low density lipoprotein and long chain fatty ac

31 -Asp-Ser and anti-alpha(v), and up to 20% by oxidized low density lipoprotein and N-acetylglucosamine

32 rythrocytes, and as a scavenger receptor for oxidized low-density lipoprotein and apoptotic neutrophi

33 cavenger receptor, binding and internalizing oxidized low-density lipoprotein and bacteria.

34 ystems because the same protein domain binds oxidized low-density lipoprotein and bacterial cell wall

35 tosis in response to sterile ligands such as oxidized low-density lipoprotein and damage-associated m

36 onses on stimulation by interferon-gamma and oxidized low-density lipoprotein and elevated antioxidan

37 d 2012-2014) over 24 years and had assays of oxidized low-density lipoprotein and fundus photographs

38 the growing body of evidence on circulating oxidized low-density lipoprotein and its relationship to

39 ry that macrophage COX-2 is downregulated by oxidized low-density lipoprotein and liver X receptors i

40 During vascular interventions, oxidized low-density lipoprotein and lysophosphatidylcho

41 xidation-specific epitopes, such as those on oxidized low-density lipoprotein and malondialdehyde-mod

42 including preventing inflammation induced by oxidized low-density lipoprotein and promoting apoptotic

43 performed a genome-wide association study on oxidized low-density lipoprotein and tested the impact o

44 ationship between increasing levels of serum oxidized low-density lipoprotein and the incidence of ma

45 tabolic signaling by proline oxidase between oxidized low-density lipoproteins and autophagy provides

46 gamma-responsive genes, CD36, a receptor for oxidized low density lipoprotein, and aP2, a fatty acid-

47 helial cells, phagocytic activity, uptake of oxidized low-density lipoprotein, and cytokine expressio

48 ension, high-sensitivity C-reactive protein, oxidized low-density lipoprotein, and low high-density l

49 ctors, the expression of NR4A1, the level of oxidized low-density lipoprotein, and the counts of diff

50 lial barrier dysfunction caused by thrombin, oxidized low-density lipoprotein, and tumor necrosis fac

51 venger receptors that mediate endocytosis of oxidized low-density lipoproteins, and adhesion to gluco

52 BDG), intestinal fatty-acid binding protein, oxidized low-density lipoproteins, and soluble CD163 wer

53 have also suggested that elevated levels of oxidized low-density lipoprotein are a prognostic indica

54 Atherogenic lipids, particularly oxidized low-density lipoprotein, are responsible for a

55 bit apoptosis in culture upon treatment with oxidized low density lipoprotein, as do vascular cells o

56 factors, we found that neither the level of oxidized low-density lipoprotein at the beginning of a p

57 will further assess the clinical utility of oxidized low-density lipoprotein biomarkers by determini

58 Research on circulating oxidized low-density lipoprotein biomarkers is rapidly a

59 bution of endothelial JAM-A was increased by oxidized low-density lipoprotein, but confined by athero

60 e scavenger receptor CD36, mediate uptake of oxidized low density lipoprotein by macrophages, and pro

61 ally, it has been assumed that the uptake of oxidized low-density lipoprotein by macrophage scavenger

62 in Fab from a patient with autoantibodies to oxidized low-density lipoproteins by phage display metho

63 ulse-wave velocity, intima-media thickening, oxidized low-density lipoprotein, Ca(2+) deposits, and g

64 oline (lysoPC), a major lipid constituent of oxidized low-density lipoprotein, can activate PKC and i

65 (LOX-1), one of the scavenger receptors for oxidized low-density lipoprotein cholesterol (ox-LDL), p

66 Oxidized low-density lipoprotein cholesterol is harmful

67 oam cell formation by reducing acetylated or oxidized low-density lipoprotein cholesterol uptake in d

68 oprotein(a), 3.0% for homocysteine, 4.2% for oxidized low-density lipoprotein cholesterol, 19.8% for

69 ing, are amplified by the harmful effects of oxidized low-density-lipoprotein cholesterol, initiating

70 benefits of exercise, as serum triglyceride, oxidized low density lipoprotein-cholesterol, and plasma

71 The levels of oxidized low-density lipoprotein collected from serum sa

72 x immobilized proteins: complement factor H, oxidized low-density lipoprotein, complement C3b, IgG, a

73 re originally selected for binding to copper-oxidized low-density lipoproteins (CuOx-LDL), also bound

74 restores endothelial function, and prevents oxidized low-density lipoprotein-dependent increases in

75 n, suppressed CD36 expression, and prevented oxidized low-density lipoprotein-derived cholesterol upt

76 Exposure of macrophages to oxidized low-density lipoprotein downregulated LKB1 in v

77 Like histamine, highly oxidized low-density lipoprotein, especially the oxidize

78 as a receptor for thrombospondin, collagen, oxidized low density lipoprotein, fatty acids, anionic p

79 phenotype and subsequently treated them with oxidized low density lipoprotein for various time period

80 s involved in the accumulation and efflux of oxidized low density lipoprotein in the arterial wall.

81 but phagocytosis is significantly reduced by oxidized low-density lipoprotein in vitro or hyperlipide

82 xposed to bacterial lipopolysaccharide or to oxidized low-density lipoprotein in vitro, and this coul

83 of LOX-1, a lectin-like 52-kDa receptor for oxidized low density lipoprotein, in TGFbeta(1)-mediated

84 Oxidized low-density lipoproteins increase arginase acti

85 biologically active lipids present in mildly oxidized low density lipoprotein, increased apolipoprote

86 of cholesterol dysregulation, generation of oxidized low-density lipoprotein, increased recruitment

87 t time that both low density lipoprotein and oxidized low density lipoprotein induce tissue factor ge

88 16 deficiency in macrophages interfered with oxidized low density lipoprotein-induced up-regulation o

89 c reticulum stress, increased sensitivity to oxidized low-density lipoprotein-induced apoptosis, and

90 rmore, genetic knockout of Epac1 obliterates oxidized low-density lipoprotein-induced cellular SUMOyl

91 truncated SIRT1 (Deltaex4) showed increased oxidized low-density lipoprotein-induced DNA damage and

92 Oxidized low-density lipoprotein induces inflammation as

93 at macrophage PI3-kinase/Akt is activated by oxidized low-density lipoprotein, inflammatory chemokine

94 Growth factors, cytokines and oxidized low density lipoproteins influence proteoglycan

95 ciated phospholipase A2 (Lp-PLA2) hydrolyses oxidized low-density lipoproteins into proinflammatory p

96 e hypothesis that the apoptotic component of oxidized low density lipoprotein is one or more oxystero

97 opulations has demonstrated that circulating oxidized low-density lipoprotein is associated with prec

98 Immunity, Lim et al. (2014) demonstrate that oxidized low-density lipoprotein is one of the key envir

99 w-risk interventions are available to modify oxidized low-density lipoprotein, it is important to exa

100 Standard lipid moieties and markers of oxidized low density lipoprotein (LDL) (immunoglobulin G

101 We have previously shown that oxidized low density lipoprotein (LDL) but not native LD

102 Oxidized low density lipoprotein (LDL) may be of central

103 Moreover, incubating human macrophages with oxidized low density lipoprotein (LDL) or acetylated LDL

104 ltifunctional receptor whose ligands include oxidized low density lipoprotein (LDL), as well as sever

105 e have previously identified a 94- to 97-kDa oxidized low density lipoprotein (LDL)-binding protein i

106 Oxidized low density lipoprotein (LDL; oxLDL) causes dis

107 that coincubation of SMC with macrophages or oxidized low density lipoproteins (LDL) from macrophage-

108 e, deposition of the altered self components oxidized low-density lipoprotein (LDL) and amyloid-beta

109 e highly susceptible to the toxic effects of oxidized low-density lipoprotein (LDL) and exhibit marke

110 Oxidant stress and oxidized low-density lipoprotein (LDL) impair endothelia

111 We demonstrate that oxidized low-density lipoprotein (LDL) induces surface t

112 Oxidized low-density lipoprotein (LDL) is an important d

113 Oxidized low-density lipoprotein (LDL) is implicated in

114 nitric oxide (NO) levels and increased serum-oxidized low-density lipoprotein (LDL) levels compared t

115 We investigated whether levels of oxidized low-density lipoprotein (LDL) measured with use

116 dothelial cells were treated with cytokines, oxidized low-density lipoprotein (LDL) or fatty acids.

117 Oxidized low-density lipoprotein (LDL) plays an essentia

118 both very low-density lipoprotein (VLDL) and oxidized low-density lipoprotein (LDL) support assembly

119 Soluble endogenous ligands, including oxidized low-density lipoprotein (LDL), amyloid-beta and

120 an atherogenic lysophospholipid contained in oxidized low-density lipoprotein (LDL), has been shown t

121 ha-tocopherol (mumol/mmol lipid) and greater oxidized low-density lipoprotein (LDL), interleukin (IL)

122 Here, we investigated the role of JAM-C in oxidized low-density lipoprotein (LDL)-mediated leukocyt

123 hersclerosis, and that such antibodies bound oxidized low-density lipoproteins (LDL) (oxLDL) in ather

124 Elevated oxidized low-density lipoproteins (LDL) are associated w

125 accumulating neutral lipids while excluding oxidized-low-density lipoprotein (LDL).

126 pro-inflammatory oxidized lipids present in oxidized low-density lipoproteins (LDLs).

127 oliferative retinopathy, with an increase in oxidized low-density lipoprotein level over the precedin

128 tic marker is an important factor regulating oxidized low-density lipoprotein levels but not a major

129 Serum-oxidized low-density lipoprotein levels were directly as

130 Lectin-like oxidized low-density lipoprotein (LOX-1), the primary re

131 n of lysophosphatidylcholine, a component of oxidized low density lipoprotein, markedly decreased apo

132 Oxidized low-density lipoprotein may be a key factor in

133 sted that autoantibodies against epitopes of oxidized low-density lipoprotein may indicate the extent

134 d-containing phospholipids present in mildly oxidized low density lipoproteins (MM-LDL) can activate

135 recognizes modified self, such as minimally oxidized low-density lipoprotein (mmLDL).

136 cohort at baseline had a mean (SD) level of oxidized low-density lipoprotein of 30.0 (8.5) U/L.

137 CD69 binding to oxidized low-density lipoprotein on T cells induces the

138 ysiological stimuli, native (unmodified) and oxidized low density lipoprotein, on tissue factor gene

139 exposed to macrophages rendered apoptotic by oxidized low density lipoprotein or UV radiation.

140 Both oxidized low density lipoprotein (ox-LDL) and platelet-d

141 es VSMC accumulation even in the presence of oxidized low density lipoprotein (Ox-LDL).

142 f the response of macrophages to exposure to oxidized low density lipoprotein (Ox-LDL).

143 gments and scavenging of apoptotic cells and oxidized low density lipoprotein (Ox-LDL).

144 Oxidized low density lipoproteins (Ox-LDL) affect severa

145 vestigated whether inflammatory cytokines or oxidized low density lipoproteins (Ox-LDL) present in hu

146 ls surface-bound, internalized, and degraded oxidized low density lipoproteins (Ox-LDL).

147 Oxidized low-density lipoprotein (ox-LDL) causes endothe

148 h sensitivity C-reactive protein (HsCRP) and oxidized low-density lipoprotein (Ox-LDL) in adolescents

149 ipoprotein (LOX-1), the primary receptor for oxidized low-density lipoprotein (ox-LDL) in endothelial

150 In the general population, oxidized low-density lipoprotein (ox-LDL) increases the

151 Oxidized low-density lipoprotein (ox-LDL) induces apopto

152 this study were to test our hypothesis that oxidized low-density lipoprotein (ox-LDL) induces the re

153 ein receptors (LOX-1), a recently identified oxidized low-density lipoprotein (ox-LDL) receptor, in i

154 -derived macrophages cultured in vitro under oxidized low-density lipoprotein (ox-LDL) stimulation.

155 Oxidized low-density lipoprotein (ox-LDL) up-regulates C

156 teins, oxidized state, and autoantibodies to oxidized low-density lipoprotein (Ox-LDL) were assessed.

157 Oxidized low-density lipoprotein (ox-LDL), an atherogeni

158 hydrogen sulfide (H2S) in the generation of oxidized low-density lipoprotein (ox-LDL)-stimulated mon

159 locally produced inflammatory cytokines and oxidized low-density lipoprotein (Ox-LDL).

160 function induced by cholesterol crystals and oxidized low-density lipoproteins (ox-LDL), potentially

161 spholipid antibodies (aPL) and antibodies to oxidized low-density lipoproteins (ox-LDL).

162 amined its expression pattern in response to oxidized low-density lipoproteins (ox-LDLs) that are bel

163 Plasma oxidized low-density lipoprotein (oxi-LDL), a measure of

164 We have shown previously that minimally oxidized low density lipoprotein, oxidized 1-palmitoyl-2

165 Oxidized low density lipoprotein (oxLDL) and macrophage

166 re identified as critical for oxPC(CD36) and oxidized low density lipoprotein (oxLDL) binding to CD36

167 The uptake of oxidized low density lipoprotein (OxLDL) by macrophages

168 tant physiological function in the uptake of oxidized low density lipoprotein (OxLDL) by macrophages.

169 an blood-derived macrophages pretreated with oxidized low density lipoprotein (OxLDL) fail to transcr

170 THP-1-derived macrophages were treated with oxidized low density lipoprotein (OxLDL) for 3 days to l

171 that acetylated low density lipoprotein and oxidized low density lipoprotein (oxLDL) increase C3 gen

172 Oxidized low density lipoprotein (oxLDL) induces apoptos

173 Oxidized low density lipoprotein (oxLDL) is inflammatory

174 of this study was to determine the effect of oxidized low density lipoprotein (oxLDL) on BMP-2 protei

175 he present study, we examined the effects of oxidized low density lipoprotein (oxLDL) on the subcellu

176 Oxidized low density lipoprotein (OxLDL) or lysophosphat

177 rmation initiated by exposing macrophages to oxidized low density lipoprotein (oxLDL) triggers the di

178 iffness of endothelial cells (EC) exposed to oxidized low density lipoprotein (oxLDL) under static an

179 actively researched, with focuses on FA and oxidized low density lipoprotein (oxLDL) uptake.

180 We have previously demonstrated that oxidized low density lipoprotein (OxLDL) will increase e

181 avenger receptors (MSR) bind and internalize oxidized low density lipoprotein (OxLDL), a modified lip

182 rray of ligands, including thrombospondin-1, oxidized low density lipoprotein (OxLDL), fatty acids, a

183 cal impedance (EIS) increased in response to oxidized low density lipoprotein (oxLDL)-laden lesions.

184 We have shown previously that oxidized low density lipoproteins (OxLDL) also can inhib

185 Oxidized low density lipoproteins (oxLDL) are among the

186 cardiomyocytes and adipocytes and uptake of oxidized low density lipoproteins (oxLDL) by macrophages

187 Apoptosis of arterial cells induced by oxidized low density lipoproteins (OxLDL) is thought to

188 Oxidized low density lipoproteins (OxLDL) promote chroni

189 Oxidized low-density lipoprotein (OxLDL) also stimulates

190 s, autoantibodies are induced to epitopes of oxidized low-density lipoprotein (oxLDL) and active immu

191 reviously we showed that interaction between oxidized low-density lipoprotein (oxLDL) and CD36 inhibi

192 sion initiation and progression by taking up oxidized low-density lipoprotein (oxLDL) and promoting i

193 ured OxPL/apoB, lipoprotein (a) [Lp(a)], and oxidized low-density lipoprotein (OxLDL) biomarkers, con

194 evaluate the uptake of fluorescently labeled oxidized low-density lipoprotein (oxLDL) by a monocyte/m

195 The uptake of oxidized low-density lipoprotein (OxLDL) by macrophage s

196 erosis and leads to the uptake of native and oxidized low-density lipoprotein (oxLDL) by macrophages

197 re under increased oxidative stress and that oxidized low-density lipoprotein (OxLDL) competes with a

198 nd smooth muscle cells (SMCs) to atherogenic oxidized low-density lipoprotein (oxLDL) enhances their

199 We previously showed that oxidized low-density lipoprotein (oxLDL) formed in the s

200 IgM autoantibodies which bind to epitopes of oxidized low-density lipoprotein (OxLDL) from apoE-defic

201 Oxidized low-density lipoprotein (oxLDL) has been report

202 rotect against atherosclerosis, whereas anti-oxidized low-density lipoprotein (oxLDL) IgG likely prom

203 Oxidized low-density lipoprotein (OxLDL) impairs NO sign

204 f scavenger receptor (SR)-mediated uptake of oxidized low-density lipoprotein (OxLDL) in atherogenesi

205 he neurotoxicity associated with exposure to oxidized low-density lipoprotein (oxLDL) in vitro, we te

206 Therefore, this study analyzed whether oxidized low-density lipoprotein (oxLDL) induces CD40/CD

207 Proatherogenic oxidized low-density lipoprotein (oxLDL) induces endothe

208 Our aim was to examine whether circulating oxidized low-density lipoprotein (oxLDL) is a predictor

209 Oxidized low-density lipoprotein (oxLDL) is considered o

210 in human aortic endothelial cells exposed to oxidized low-density lipoprotein (OxLDL) is consistent w

211 Oxidized low-density lipoprotein (oxLDL) is known to act

212 Macrophage uptake of oxidized low-density lipoprotein (oxLDL) is thought to p

213 This study was performed to assess whether oxidized low-density lipoprotein (OxLDL) levels are elev

214 However, D-4F treatment reduced the plasma oxidized low-density lipoprotein (oxLDL) levels in mice

215 Mphis were cultured for 24 h with oxidized low-density lipoprotein (oxLDL) or cholesterol

216 receptor CD36 recognizes oxidized lipids in oxidized low-density lipoprotein (oxLDL) particles, a pr

217 Oxidized low-density lipoprotein (oxLDL) promotes unregu

218 o test the hypothesis that plasma markers of oxidized low-density lipoprotein (OxLDL) reflect acute c

219 tural prooxidant and proatherogenic molecule oxidized low-density lipoprotein (OxLDL) to determine a

220 as been shown previously that the binding of oxidized low-density lipoprotein (OxLDL) to resident mou

221 In vitro, oxidized low-density lipoprotein (OxLDL), a key factor i

222 lerotic plaques by antibodies that recognize oxidized low-density lipoprotein (OxLDL), but none have

223 Oxidized low-density lipoprotein (oxLDL), but not native

224 at contrary to the prothrombotic activity of oxidized low-density lipoprotein (OxLDL), HDL upon oxida

225 Retained oxidized low-density lipoprotein (oxLDL), in turn, stimu

226 and macrophages to beta-amyloid fibrils and oxidized low-density lipoprotein (oxLDL)-coated surfaces

227 eport a novel mechanistic connection between oxidized low-density lipoprotein (oxLDL)-induced prothro

228 receptors that internalize lipids, including oxidized low-density lipoprotein (oxLDL).

229 acterial antigens and human antigens such as oxidized low-density lipoprotein (oxLDL).

230 ylated low-density lipoprotein (glycLDL) and oxidized low-density lipoprotein (oxLDL).

231 ion of scavenger receptors and the uptake of oxidized low-density lipoprotein (oxLDL).

232 ors associated with soluble CD14 (sCD14) and oxidized low-density lipoprotein (oxLDL).

233 bly inhibited by antibodies directed against oxidized low-density lipoprotein (oxLDL).

234 ce they are in low abundance in samples like oxidized low-density lipoproteins (OxLDL) and human plas

235 elopment by facilitating the accumulation of oxidized low-density lipoproteins (oxLDL) and increasing

236 The uptake of oxidized low-density lipoproteins (oxLDL) by macrophages

237 Oxidized low-density lipoproteins (oxLDL) generated in t

238 ly in response to exposure to an NO donor or oxidized low-density lipoproteins (oxLDL) increases p21r

239 Mechanistically, CD36 promoted uptake of oxidized low-density lipoproteins (OxLDL) into T cells,

240 and in endothelial cells (ECs) treated with oxidized low-density lipoproteins (oxLDL).

241 In the oxidized low-density-lipoprotein (oxLDL)-rich lesions fr

242 poE(-/-) mice; and 3) proatherogenic lipids (oxidized low density lipoprotein [oxLDL] and oxidized li

243 Oxidized low-density lipoproteins (OxLDLs), in particula

244 CL16, a chemokine and scavenger receptor for oxidized low-density lipoproteins (OxLDLs), regardless o

245 ) or smooth muscle cell (SMC) contact and by oxidized low-density lipoproteins (oxLDLs).

246 Oxidized low-density lipoprotein, oxysterols, and synthe

247 ost common phospholipid oxidation product of oxidized low density lipoprotein, phosphatidylcholine wi

248 tumor spread, invasion and angiogenesis, and oxidized low-density lipoprotein, playing a role in inhi

249 Oxidized low-density lipoprotein plays a key role in the

250 Oxidized low-density lipoprotein plays a major role in a

251 orroborated the contributing role of C5l2 in oxidized low-density lipoprotein-pretreated C5a-induced

252 ude that macrophage LKB1 reduction caused by oxidized low-density lipoprotein promotes foam cell form

253 ulation of murine and human macrophages with oxidized low-density lipoprotein recapitulated some of t

254 e entire intracellular domain of lectin-like oxidized low density lipoprotein receptor 1 or SR expres

255 three members of the SR family (lectin-like oxidized low density lipoprotein receptor 1; fasciclin,

256 The lectin-like oxidized low density lipoprotein receptor-1 (Lox-1) medi

257 ger receptor (SR)-A, SR-BII, and lectin-like oxidized low-density lipoprotein receptor (LOX-1); the n

258 telet-activating factor acetylhydrolase, and oxidized low-density lipoprotein receptor 1 (OLR1).

259 ombosis; and (99m)Tc-labeled anti-lectinlike oxidized low-density lipoprotein receptor 1 antibody, wh

260 tor 1 antibody, which detects the lectinlike oxidized low-density lipoprotein receptor 1 that is over

261 eptide of transforming growth factor beta 1, oxidized low-density lipoprotein receptor 1, and C-C mot

262 foamy niche within macrophage by modulating oxidized low-density lipoprotein receptor CD36, phagolys

263 Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is a

264 avenger receptor type AI/AII and lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) was

265 Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), one

266 LPS) resulted in upregulation (~1.5 fold) of oxidized low-density lipoprotein receptor-1 (LOX-1).

267 expression of CD36, SR-BII, and lectin-like oxidized low-density lipoprotein receptor-1 were down-re

268 LOX-1 (lectin-like oxidized low-density lipoprotein receptor-1), a membrane

269 CD36 and CD68, SR-A and SR-BII, lectin-like oxidized low-density lipoprotein receptor-1, the nuclear

270 udy was to determine the role of lectin-like oxidized low-density lipoprotein receptors (LOX-1), a re

271 Lectin-like oxidized low-density lipoprotein receptors are upregulat

272 Oxidized low-density lipoprotein reduces endothelial nit

273 Application of oxidized low-density lipoprotein resulted in an increase

274 Native and oxidized low density lipoprotein retention within arteri

275 risk factors, including serum nitric oxide, oxidized low-density lipoprotein, serum amyloid A, and l

276 mice, which have high autoantibody titers to oxidized low density lipoprotein, showed a striking time

277 The proinflammatory cytokines and oxidized low-density lipoprotein significantly increased

278 o = -0.25 [P = .04] and -0.26 [P = .04]) and oxidized low-density lipoprotein (Spearman rho = 0.24 [P

279 sed splenic CD11c+ B cells and reduced serum oxidized low-density lipoprotein-specific IgG2c.

280 ough induction of IL-5-producing T cells and oxidized low-density lipoprotein-specific IgM and reduct

281 s increased, thus enhancing atheroprotective oxidized low-density lipoprotein-specific IgM production

282 Autoantibodies recognizing model epitopes of oxidized low density lipoprotein, such as malondialdehyd

283 oxy-delta prostaglandin J2 and components of oxidized low-density lipoprotein, such as 13-hydroxyocta

284 n was blocked 50% by PS liposomes and 40% by oxidized low density lipoprotein, suggesting that the ma

285 Studies have shown oxidized low-density lipoprotein to be associated with t

286 bolites, isoprostanes) and autoantibodies to oxidized low-density lipoprotein to risk for atheroscler

287 R4 has any influence on foam cell outcome in oxidized low-density lipoprotein-treated macrophages.

288 erotic lesions and that in vitro exposure to oxidized low-density lipoprotein up-regulates alphaVbeta

289 ired for 15(S)-HETE-induced CD36 expression, oxidized low density lipoprotein uptake, and foam cell f

290 activation, cellular adhesion, phagocytosis, oxidized low-density lipoprotein uptake, and expression

291 and induced monocyte lipid accumulation from oxidized low-density lipoprotein via the CD36 scavenger

292 ignificant decrease in binding and uptake of oxidized low density lipoprotein was observed in periton

293 xpression in rat aortic smooth muscle cells; oxidized low density lipoprotein was slightly more poten

294 bility to inactivate lipid hydroperoxides in oxidized low-density lipoprotein was carried predominant

295 Oxidized low-density lipoprotein was shown to bind speci

296 lipoprotein-associated phospholipase A2, and oxidized low-density lipoprotein were assessed in a subg

297 cavenger receptor for phosphatidylserine and oxidized low-density lipoprotein were independently iden

298 -B1 for high-density lipoprotein or CD36 for oxidized low-density lipoprotein, when comparing glycosy

299 cavenger receptor for phosphatidylserine and oxidized low density lipoprotein, which is highly expres

300 Oxidized low-density lipoprotein, which plays a central